LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 17

Suchoptionen

  1. Artikel ; Online: Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population.

    González-Stegmaier, R / Cereceda, K / Briones, J L / Beltran-Pávez, C / Oyarzún-Arrau, A / Riquelme-Barrios, S / Selman, C / Yarad, F / Mahave, M / Caglevic, C / Morales, R / Aguirre, A / Valiente-Echeverría, F / Soto-Rifo, R / Marsiglia, H / Gazitua, R / Villarroel-Espindola, F

    Journal of immunology research

    2021  Band 2021, Seite(n) 6680337

    Abstract: COVID-19 is a pandemic caused by SARS-CoV-2. In Chile, half a million people have been infected and more than 16,000 have died from COVID-19. As part of the clinical trial NCT04384588, we quantified IgG against S1-RBD of SARS-CoV-2 (anti-RBD) in ... ...

    Abstract COVID-19 is a pandemic caused by SARS-CoV-2. In Chile, half a million people have been infected and more than 16,000 have died from COVID-19. As part of the clinical trial NCT04384588, we quantified IgG against S1-RBD of SARS-CoV-2 (anti-RBD) in recovered people in Santiago and evaluated their suitability as COVID-19 convalescent plasma donors. ELISA and a luminescent SARS-CoV-2 pseudotype were used for IgG and neutralizing antibody quantification. 72.9% of the convalescent population (468 of 639) showed seroconversion (5-55
    Mesh-Begriff(e) Adolescent ; Adult ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/therapeutic use ; Antibodies, Viral/blood ; Antibodies, Viral/therapeutic use ; COVID-19/immunology ; COVID-19/therapy ; Chile ; Female ; Humans ; Immunization, Passive/methods ; Immunoglobulin G/blood ; Male ; Middle Aged ; Pandemics ; SARS-CoV-2/physiology ; Seroconversion ; Spike Glycoprotein, Coronavirus/immunology ; Young Adult ; COVID-19 Serotherapy
    Chemische Substanzen Antibodies, Neutralizing ; Antibodies, Viral ; Immunoglobulin G ; Spike Glycoprotein, Coronavirus
    Sprache Englisch
    Erscheinungsdatum 2021-02-19
    Erscheinungsland Egypt
    Dokumenttyp Clinical Trial ; Journal Article
    ZDB-ID 2817541-4
    ISSN 2314-7156 ; 2314-7156
    ISSN (online) 2314-7156
    ISSN 2314-7156
    DOI 10.1155/2021/6680337
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel: Accuracy of a RT-qPCR SARS-CoV-2 detection assay without prior RNA extraction

    Beltrán-Pavez, Carolina / Alonso-Palomares, Luis A. / Valiente-Echeverría, Fernando / Gaggero, Aldo / Soto-Rifo, Ricardo / Barriga, Gonzalo P.

    Journal of virological methods. 2021 Jan., v. 287

    2021  

    Abstract: The current COVID‐19 pandemic constitutes a threat to the population worldwide with over 21 million infected people. There is an urgent need for the development of rapid and massive detection tools as well as the identification and isolation of infected ... ...

    Abstract The current COVID‐19 pandemic constitutes a threat to the population worldwide with over 21 million infected people. There is an urgent need for the development of rapid and massive detection tools as well as the identification and isolation of infected individuals. we sought to evaluate different RT-qPCR kits and protocols to evaluate the best approach to be used omitting an RNA extraction step. We have investigated the sensitivity and performance of different commercially available RT-qPCR kits in detecting SARS-CoV-2 using 80 extracted RNA and NSS from COVID-19 diagnosed patients. We evaluated the ability of each kit to detect viral RNA from both kit-extracted or directly from a pre-boiled NSS observing that direct RNA detection is possible when Ct values are lower than 30 with the three kits tested. Since SARS-CoV-2 testing in most locations occurs once COVID-19 symptoms are evident and, therefore, viral loads are expected to be high, our protocol will be useful in supporting SARS-CoV-2 diagnosis, especially in America where COVID-19 cases have exploded in the recent weeks as well as in low- and middle-income countries, which would not have massive access to kit-based diagnosis. The information provided in this work paves the way for the development of more efficient SARS-CoV-2 detection approaches avoiding an RNA extraction step.
    Schlagwörter COVID-19 infection ; RNA ; Severe acute respiratory syndrome coronavirus 2
    Sprache Englisch
    Erscheinungsverlauf 2021-01
    Erscheinungsort Elsevier B.V.
    Dokumenttyp Artikel
    ZDB-ID 8013-5
    ISSN 1879-0984 ; 0166-0934
    ISSN (online) 1879-0984
    ISSN 0166-0934
    DOI 10.1016/j.jviromet.2020.113969
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain.

    Epalza, Cristina / Valadés-Alcaraz, Ana / González-Alba, José María / Beltrán-Pavez, Carolina / Gutiérrez-López, Miguel / Rubio-Garrido, Marina / Fortuny, Clàudia / Frick, Marie Antoinette / Muñoz Medina, Leopoldo / Moreno, Santiago / Sanz, José / Rojo, Pablo / Navarro, María Luisa / Holguín, África

    The Pediatric infectious disease journal

    2023  Band 43, Heft 1, Seite(n) 40–48

    Abstract: Background: Virologic characterization of newly HIV-diagnosed adolescents could help to improve their specific needs. The objective was to describe the transmitted drug resistance mutations (TDR) and its transmission by clusters in this population in ... ...

    Abstract Background: Virologic characterization of newly HIV-diagnosed adolescents could help to improve their specific needs. The objective was to describe the transmitted drug resistance mutations (TDR) and its transmission by clusters in this population in Spain.
    Methods: TDR to retrotranscriptase and protease inhibitors included in the WHO TDR list 2009 implemented in the Calibrated Population Resistance tool v8.0 (Stanford) were studied in HIV pol sequences from all HIV-diagnosed adolescents (12-19-year-old) enrolled during 2004-2019 period in the Spanish pediatric and adult (CoRISpe-CoRIS) cohorts. The found TDR were compared with the provided by the Stanford algorithm v9.0 2021. HIV-1 variants and transmission clusters were also studied.
    Results: Among 410 HIV-1 adolescents diagnosed, 141 (34.4%) had available ART-naive sequences. They were mostly male (81.6%), Spanish (55.3%) and with behavioral risk (92.2%), mainly male-to-male sexual contact (63.1%). TDR prevalence was significantly higher by Stanford versus WHO list (18.4% vs. 7.1%; P = 0.004). The most prevalent TDR by the WHO list was K103N (3.6%) and by Stanford E138A (6.6%), both at retrotranscriptase. E138A, related to rilpivirine/etravirine resistance, was absent in the WHO list. One in 4 adolescents carried HIV-1 non-B variants. We described 5 transmission clusters, and 2 carried TDR mutations.
    Conclusions: Our data suggest a high TDR prevalence in adolescents with a new HIV diagnosis in Spain, similar to adults, 2 active TDR transmission clusters, and the need for the WHO TDR list update. These findings could have implications for the options of the recently available rilpivirine-related long-acting treatment and in first-line regimen election.
    Mesh-Begriff(e) Adult ; Humans ; Male ; Adolescent ; Child ; Young Adult ; Female ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; Spain/epidemiology ; Drug Resistance, Viral/genetics ; HIV Seropositivity ; Mutation ; HIV-1/genetics ; Rilpivirine/therapeutic use ; Prevalence ; Genotype ; Anti-HIV Agents/pharmacology ; Anti-HIV Agents/therapeutic use
    Chemische Substanzen Rilpivirine (FI96A8X663) ; Anti-HIV Agents
    Sprache Englisch
    Erscheinungsdatum 2023-11-16
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 392481-6
    ISSN 1532-0987 ; 0891-3668
    ISSN (online) 1532-0987
    ISSN 0891-3668
    DOI 10.1097/INF.0000000000004138
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Accuracy of a RT-qPCR SARS-CoV-2 detection assay without prior RNA extraction.

    Beltrán-Pavez, Carolina / Alonso-Palomares, Luis A / Valiente-Echeverría, Fernando / Gaggero, Aldo / Soto-Rifo, Ricardo / Barriga, Gonzalo P

    Journal of virological methods

    2020  Band 287, Seite(n) 113969

    Abstract: The current COVID-19 pandemic constitutes a threat to the population worldwide with over 21 million infected people. There is an urgent need for the development of rapid and massive detection tools as well as the identification and isolation of infected ... ...

    Abstract The current COVID-19 pandemic constitutes a threat to the population worldwide with over 21 million infected people. There is an urgent need for the development of rapid and massive detection tools as well as the identification and isolation of infected individuals. we sought to evaluate different RT-qPCR kits and protocols to evaluate the best approach to be used omitting an RNA extraction step. We have investigated the sensitivity and performance of different commercially available RT-qPCR kits in detecting SARS-CoV-2 using 80 extracted RNA and NSS from COVID-19 diagnosed patients. We evaluated the ability of each kit to detect viral RNA from both kit-extracted or directly from a pre-boiled NSS observing that direct RNA detection is possible when Ct values are lower than 30 with the three kits tested. Since SARS-CoV-2 testing in most locations occurs once COVID-19 symptoms are evident and, therefore, viral loads are expected to be high, our protocol will be useful in supporting SARS-CoV-2 diagnosis, especially in America where COVID-19 cases have exploded in the recent weeks as well as in low- and middle-income countries, which would not have massive access to kit-based diagnosis. The information provided in this work paves the way for the development of more efficient SARS-CoV-2 detection approaches avoiding an RNA extraction step.
    Mesh-Begriff(e) COVID-19/diagnosis ; COVID-19/virology ; COVID-19 Nucleic Acid Testing/methods ; Humans ; Nasopharynx/virology ; RNA, Viral/genetics ; RNA, Viral/isolation & purification ; Reagent Kits, Diagnostic ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification ; Sensitivity and Specificity ; Specimen Handling/methods ; Time Factors ; Viral Load
    Chemische Substanzen RNA, Viral ; Reagent Kits, Diagnostic
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-09-09
    Erscheinungsland Netherlands
    Dokumenttyp Evaluation Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 8013-5
    ISSN 1879-0984 ; 0166-0934
    ISSN (online) 1879-0984
    ISSN 0166-0934
    DOI 10.1016/j.jviromet.2020.113969
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.

    Beltran-Pavez, Carolina / Bontjer, Ilja / Gonzalez, Nuria / Pernas, Maria / Merino-Mansilla, Alberto / Olvera, Alex / Miro, Jose M / Brander, Christian / Alcami, Jose / Sanders, Rogier W / Sanchez-Merino, Victor / Yuste, Eloisa

    Journal of virology

    2021  Band 96, Heft 1, Seite(n) e0134321

    Abstract: Longitudinal studies in HIV-1-infected individuals have indicated that 2 to 3 years of infection are required to develop broadly neutralizing antibodies. However, we have previously identified individuals with broadly neutralizing activity (bNA) in early ...

    Abstract Longitudinal studies in HIV-1-infected individuals have indicated that 2 to 3 years of infection are required to develop broadly neutralizing antibodies. However, we have previously identified individuals with broadly neutralizing activity (bNA) in early HIV-1 infection, indicating that a vaccine may be capable of bNA induction after short periods of antigen exposure. Here, we describe 5 HIV-1 envelope sequences from individuals who have developed bNA within the first 100 days of infection (early neutralizers) and selected two of them to design immunogens based on HIV-1-Gag virus-like particles (VLPs). These VLPs were homogeneous and incorporated the corresponding envelopes (7 to 9 μg of gp120 in 10
    Mesh-Begriff(e) AIDS Vaccines/immunology ; Adult ; Antibodies, Neutralizing/immunology ; Antibody Formation ; Broadly Neutralizing Antibodies/immunology ; CD4 Lymphocyte Count ; CD4-CD8 Ratio ; Epitope Mapping ; Epitopes/immunology ; Female ; HIV Antibodies/chemistry ; HIV Antibodies/immunology ; HIV Infections/immunology ; HIV Infections/virology ; HIV-1/immunology ; Host-Pathogen Interactions/immunology ; Humans ; Immunization ; Male ; Middle Aged ; Models, Molecular ; Protein Conformation ; Structure-Activity Relationship ; Vaccines, Virus-Like Particle/immunology ; env Gene Products, Human Immunodeficiency Virus/chemistry ; env Gene Products, Human Immunodeficiency Virus/immunology
    Chemische Substanzen AIDS Vaccines ; Antibodies, Neutralizing ; Broadly Neutralizing Antibodies ; Epitopes ; HIV Antibodies ; Vaccines, Virus-Like Particle ; env Gene Products, Human Immunodeficiency Virus
    Sprache Englisch
    Erscheinungsdatum 2021-10-20
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 80174-4
    ISSN 1098-5514 ; 0022-538X
    ISSN (online) 1098-5514
    ISSN 0022-538X
    DOI 10.1128/JVI.01343-21
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: SARS-CoV-2 detection from nasopharyngeal swab samples without RNA extraction

    Beltrán-Pavez, Carolina / Márquez, Chantal L. / Muñoz, Gabriela / Valiente-Echeverría, Fernando / Gaggero, Aldo / Soto-Rifo, Ricardo / Barriga, Gonzalo P.

    bioRxiv

    Abstract: The ongoing COVID-19 pandemic has reached more than 200 countries and territories worldwide. Given the large requirement of SARS-CoV-2 diagnosis and considering that RNA extraction kits are in short supply, we investigated whether two commercial RT-qPCR ... ...

    Abstract The ongoing COVID-19 pandemic has reached more than 200 countries and territories worldwide. Given the large requirement of SARS-CoV-2 diagnosis and considering that RNA extraction kits are in short supply, we investigated whether two commercial RT-qPCR kits were compatible with direct SARS-CoV-2 detection from nasopharyngeal swab samples. We show that one of the tested kits is fully compatible with direct SARS-CoV-2 detection suggesting that omission of RNA extraction step should be considered in SARS-CoV-2 diagnosis.
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-03-30
    Verlag Cold Spring Harbor Laboratory
    Dokumenttyp Artikel ; Online
    DOI 10.1101/2020.03.28.013508
    Datenquelle COVID19

    Kategorien

  7. Artikel: Accuracy of a RT-qPCR SARS-CoV-2 detection assay without prior RNA extraction

    Beltrán-Pavez, Carolina / Alonso-Palomares, Luis A / Valiente-Echeverría, Fernando / Gaggero, Aldo / Soto-Rifo, Ricardo / Barriga, Gonzalo P

    J Virol Methods

    Abstract: The current COVID-19 pandemic constitutes a threat to the population worldwide with over 21 million infected people. There is an urgent need for the development of rapid and massive detection tools as well as the identification and isolation of infected ... ...

    Abstract The current COVID-19 pandemic constitutes a threat to the population worldwide with over 21 million infected people. There is an urgent need for the development of rapid and massive detection tools as well as the identification and isolation of infected individuals. we sought to evaluate different RT-qPCR kits and protocols to evaluate the best approach to be used omitting an RNA extraction step. We have investigated the sensitivity and performance of different commercially available RT-qPCR kits in detecting SARS-CoV-2 using 80 extracted RNA and NSS from COVID-19 diagnosed patients. We evaluated the ability of each kit to detect viral RNA from both kit-extracted or directly from a pre-boiled NSS observing that direct RNA detection is possible when Ct values are lower than 30 with the three kits tested. Since SARS-CoV-2 testing in most locations occurs once COVID-19 symptoms are evident and, therefore, viral loads are expected to be high, our protocol will be useful in supporting SARS-CoV-2 diagnosis, especially in America where COVID-19 cases have exploded in the recent weeks as well as in low- and middle-income countries, which would not have massive access to kit-based diagnosis. The information provided in this work paves the way for the development of more efficient SARS-CoV-2 detection approaches avoiding an RNA extraction step.
    Schlagwörter covid19
    Verlag WHO
    Dokumenttyp Artikel
    Anmerkung WHO #Covidence: #753173
    Datenquelle COVID19

    Kategorien

  8. Artikel ; Online: SARS-CoV-2 detection from nasopharyngeal swab samples without RNA extraction

    Beltrán-Pavez, Carolina / Márquez, Chantal L. / Muñoz, Gabriela / Valiente-Echeverría, Fernando / Gaggero, Aldo / Soto-Rifo, Ricardo / Barriga, Gonzalo P.

    bioRxiv

    Abstract: The ongoing COVID-19 pandemic has reached more than 200 countries and territories worldwide. Given the large requirement of SARS-CoV-2 diagnosis and considering that RNA extraction kits are in short supply, we investigated whether two commercial RT-qPCR ... ...

    Abstract The ongoing COVID-19 pandemic has reached more than 200 countries and territories worldwide. Given the large requirement of SARS-CoV-2 diagnosis and considering that RNA extraction kits are in short supply, we investigated whether two commercial RT-qPCR kits were compatible with direct SARS-CoV-2 detection from nasopharyngeal swab samples. We show that one of the tested kits is fully compatible with direct SARS-CoV-2 detection suggesting that omission of an RNA extraction step should be considered in SARS-CoV-2 diagnosis.
    Schlagwörter covid19
    Verlag BioRxiv; WHO
    Dokumenttyp Artikel ; Online
    DOI 10.1101/2020.03.28.013508
    Datenquelle COVID19

    Kategorien

  9. Artikel ; Online: Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997-2017).

    Beltrán-Pavez, Carolina / Gutiérrez-López, Miguel / Rubio-Garrido, Marina / Valadés-Alcaraz, Ana / Prieto, Luis / Ramos, José Tomás / Jiménez De Ory, Santiago / Navarro, Marisa / Díez-Romero, Cristina / Pulido, Federico / Valencia, Eulalia / Holguín, África

    Scientific reports

    2020  Band 10, Heft 1, Seite(n) 16891

    Abstract: The aim of this transversal study was to describe the virological and immunological features of HIV-infected youths transferred from pediatric to adult care units since 1997 vs. the non-transferred patients from the Madrid Cohort of HIV-infected children ...

    Abstract The aim of this transversal study was to describe the virological and immunological features of HIV-infected youths transferred from pediatric to adult care units since 1997 vs. the non-transferred patients from the Madrid Cohort of HIV-infected children and adolescents in Spain. We included 106 non-transferred and 184 transferred patients under clinical follow-up in 17 public hospitals in Madrid by the end of December 2017. Virological and immunological outcomes were compared in transferred vs. non-transferred patients. ART drug resistance mutations and HIV-variants were analyzed in all subjects with available resistance pol genotypes and/or genotypic resistance profiles. Among the study cohort, 133 (72.3%) of 184 transferred and 75 (70.7%) of 106 non-transferred patients had available resistance genotypes. Most (88.9%) of transferred had ART experience at sampling. A third (33.3%) had had a triple-class experience. Acquired drug resistance (ADR) prevalence was significantly higher in pretreated transferred than non-transferred patients (71.8% vs. 44%; p = 0.0009), mainly to NRTI (72.8% vs. 31.1%; p < 0.0001) and PI (29.1% vs. 12%; p = 0.0262). HIV-1 non-B variants were less frequent in transferred vs. non-transferred (6.9% vs. 32%; p < 0.0001). In conclusion, the frequent resistant genotypes found in transferred youths justifies the reinforcement of HIV resistance monitoring after the transition to avoid future therapeutic failures.
    Mesh-Begriff(e) Adolescent ; Adult ; Anti-HIV Agents/therapeutic use ; Child ; Child, Preschool ; Cohort Studies ; Drug Resistance, Viral/genetics ; Female ; Genotype ; HIV Infections/drug therapy ; HIV Infections/genetics ; HIV Infections/virology ; HIV-1/drug effects ; HIV-1/genetics ; Humans ; Infant ; Male ; Mutation/genetics ; Pediatrics ; Spain ; Viral Load/genetics ; Young Adult
    Chemische Substanzen Anti-HIV Agents
    Sprache Englisch
    Erscheinungsdatum 2020-10-09
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-020-70861-x
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure.

    Jiménez de Ory, Santiago / Beltrán-Pavez, Carolina / Gutiérrez-López, Miguel / Santos, María Del Mar / Prieto, Luis / Sainz, Talía / Guillen, Sara / Aguilera-Alonso, David / Díez, Cristina / Bernardino, Jose Ignacio / Mellado, María José / Ramos, José Tomás / Holguín, África / Navarro, Marisa

    The Journal of antimicrobial chemotherapy

    2021  Band 76, Heft 7, Seite(n) 1886–1892

    Abstract: Objectives: We analysed the prevalence of M184V/I and/or K65R/E/N mutations archived in proviral DNA (pDNA) in youths with perinatal HIV, virological control and who previously carried these resistance mutations in historic plasma samples.: Methods: ... ...

    Abstract Objectives: We analysed the prevalence of M184V/I and/or K65R/E/N mutations archived in proviral DNA (pDNA) in youths with perinatal HIV, virological control and who previously carried these resistance mutations in historic plasma samples.
    Methods: We included vertically HIV-infected youths/young adults aged ≥10 years in the Madrid Cohort of HIV-1 Infected Children and Adolescents, exposed to lamivudine and/or emtricitabine, with M184V/I and/or K65R/E/N in historic plasma samples, on antiretroviral therapy (ART), virologically suppressed (HIV-1 RNA <50 copies/mL), and with available PBMCs in the Spanish HIV BioBank. Genomic DNA was extracted from PBMCs and HIV-1 RT gene was amplified and sequenced for resistance testing by Stanford HIV Resistance tool.
    Results: Among the 225 patients under follow-up in the study cohort, 13 (5.8%) met selection criteria, and RT sequences were recovered in 12 (92.3%) of them. All but one were Spaniards, carrying subtype B, with a median age at PBMCs sampling of 21.3 years (IQR: 15.6-23.1) with 4 years (IQR 2.1-6.5) of suppressed viral load (VL). Nine (75%) youths did not present M184V/I in pDNA after at least 1 year of viral suppression. In December 2019, the remaining three subjects carrying M184V/I in pDNA maintained suppressed viraemia, and two still used emtricitabine in ART.
    Conclusions: The prevalence of resistance mutations to lamivudine and emtricitabine in pDNA in a cohort of youths perinatally infected with HIV who remain with undetectable VL, previously lamivudine and/or emtricitabine experienced, was infrequent. Our results indicate that ART including lamivudine or emtricitabine may also be safe and successful in youths with perinatal HIV with previous experience of and resistances to these drugs detected in plasma.
    Mesh-Begriff(e) Adolescent ; Anti-HIV Agents/pharmacology ; Anti-HIV Agents/therapeutic use ; Child ; DNA ; Drug Resistance, Viral ; Emtricitabine/therapeutic use ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; Humans ; Lamivudine/therapeutic use ; Prevalence ; Proviruses/genetics ; Viral Load
    Chemische Substanzen Anti-HIV Agents ; Lamivudine (2T8Q726O95) ; DNA (9007-49-2) ; Emtricitabine (G70B4ETF4S)
    Sprache Englisch
    Erscheinungsdatum 2021-03-18
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 191709-2
    ISSN 1460-2091 ; 0305-7453
    ISSN (online) 1460-2091
    ISSN 0305-7453
    DOI 10.1093/jac/dkab080
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang